Mayinglong Pharmaceutical Group Co., Ltd. (SHA:600993)
25.62
-0.19 (-0.74%)
Apr 30, 2025, 3:00 PM CST
SHA:600993 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Apr '25 Apr 29, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Market Capitalization | 11,044 | 11,255 | 10,423 | 9,742 | 12,397 | 8,681 | Upgrade
|
Market Cap Growth | 10.00% | 7.98% | 6.99% | -21.42% | 42.80% | 15.15% | Upgrade
|
Enterprise Value | 8,481 | 8,616 | 8,279 | 7,569 | 10,698 | 6,956 | Upgrade
|
Last Close Price | 25.62 | 26.11 | 23.82 | 21.97 | 27.52 | 19.07 | Upgrade
|
PE Ratio | 20.64 | 21.31 | 23.52 | 20.36 | 26.68 | 20.72 | Upgrade
|
Forward PE | 16.91 | 21.80 | 21.80 | 21.80 | 21.80 | 21.80 | Upgrade
|
PS Ratio | 2.95 | 3.02 | 3.32 | 2.76 | 3.66 | 3.11 | Upgrade
|
PB Ratio | 2.50 | 2.68 | 2.69 | 2.69 | 3.74 | 2.95 | Upgrade
|
P/TBV Ratio | 2.66 | 2.85 | 2.88 | 2.84 | 3.99 | 3.11 | Upgrade
|
P/FCF Ratio | 28.03 | 38.31 | 29.30 | 36.51 | 23.30 | 36.54 | Upgrade
|
P/OCF Ratio | 18.67 | 22.62 | 17.26 | 28.50 | 20.76 | 30.68 | Upgrade
|
PEG Ratio | - | 1.56 | 1.56 | 1.56 | 1.56 | 1.56 | Upgrade
|
EV/Sales Ratio | 2.27 | 2.31 | 2.64 | 2.14 | 3.16 | 2.49 | Upgrade
|
EV/EBITDA Ratio | 12.35 | 12.85 | 19.38 | 13.99 | 21.61 | 18.10 | Upgrade
|
EV/EBIT Ratio | 13.52 | 13.92 | 21.52 | 15.32 | 23.60 | 19.93 | Upgrade
|
EV/FCF Ratio | 21.52 | 29.33 | 23.28 | 28.36 | 20.11 | 29.28 | Upgrade
|
Debt / Equity Ratio | 0.05 | 0.06 | 0.07 | 0.18 | 0.06 | 0.05 | Upgrade
|
Debt / EBITDA Ratio | 0.31 | 0.35 | 0.59 | 1.11 | 0.35 | 0.35 | Upgrade
|
Debt / FCF Ratio | 0.54 | 0.80 | 0.77 | 2.39 | 0.34 | 0.56 | Upgrade
|
Asset Turnover | 0.72 | 0.75 | 0.63 | 0.77 | 0.85 | 0.78 | Upgrade
|
Inventory Turnover | 7.10 | 7.23 | 6.00 | 6.27 | 6.94 | 6.14 | Upgrade
|
Quick Ratio | 4.21 | 4.51 | 5.03 | 4.38 | 4.43 | 3.40 | Upgrade
|
Current Ratio | 4.60 | 4.94 | 5.54 | 4.92 | 5.05 | 3.88 | Upgrade
|
Return on Equity (ROE) | 13.13% | 13.59% | 12.07% | 13.83% | 15.14% | 15.43% | Upgrade
|
Return on Assets (ROA) | 7.50% | 7.73% | 4.85% | 6.70% | 7.09% | 6.10% | Upgrade
|
Return on Capital (ROIC) | 8.77% | 9.02% | 5.73% | 7.97% | 8.62% | 7.58% | Upgrade
|
Return on Capital Employed (ROCE) | 13.70% | 14.10% | 9.30% | 11.70% | 13.10% | 11.40% | Upgrade
|
Earnings Yield | 4.84% | 4.69% | 4.25% | 4.91% | 3.75% | 4.83% | Upgrade
|
FCF Yield | 3.57% | 2.61% | 3.41% | 2.74% | 4.29% | 2.74% | Upgrade
|
Dividend Yield | 1.56% | - | 1.68% | 1.59% | 1.27% | 1.57% | Upgrade
|
Payout Ratio | 32.85% | 33.57% | 36.71% | 34.49% | 26.80% | 27.59% | Upgrade
|
Buyback Yield / Dilution | 0.23% | 0.23% | 0.19% | -0.22% | 0.43% | -0.81% | Upgrade
|
Total Shareholder Return | 1.79% | 0.23% | 1.87% | 1.37% | 1.70% | 0.76% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.